Of interest, total antioxidant status and ceruloplasmin level were reduced of about 21.2% and 15.1%, respectively, in the serum of COVID-19 rather than No COVID-19 patients, while no differences in serum SOD activity were observed between the two groups (Fig. 1b). This evidence concerns the gene SOD1 and COVID-19.